Insider Trading activities of Momenta Pharmaceuticals Inc insiders. , Part 3

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Momenta Pharmaceuticals Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Momenta Pharmaceuticals Inc since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Momenta Pharmaceuticals Inc since 2005. The reporting company's ticker symbol is MNTA. The reporting company's CIK number is 1235010.
The total value of stock buying since 2005 is $0.
The total value of stock sales since 2005 is $75,395,716.
The total value of stock option exercises since 2005 is $11,001,864.



Table 2. Detailed insider stock purchases, sales, and option exercises of Momenta Pharmaceuticals Inc insiders (MNTA) , Part 3
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2014-02-20 Wheeler Craig A (President) Sale 6,750 17.68 119,340
2014-02-19 Roach James M. (Senior VP, Development and Chi) Sale 197 17.86 3,518
2014-02-19 Leicher Bruce (SVP & General Counsel) Sale 197 17.86 3,518
2014-02-19 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 433 17.86 7,733
2014-02-19 Shea Richard P (SVP, CFO) Sale 197 17.86 3,518
2014-02-19 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 217 17.86 3,875
2014-02-19 Wheeler Craig A (President) Sale 2,110 17.86 37,684
2014-02-18 Roach James M. (Senior VP, Development and Chi) Sale 217 17.96 3,897
2014-02-18 Leicher Bruce (SVP & General Counsel) Sale 268 17.96 4,813
2014-02-18 Shea Richard P (SVP, CFO) Sale 145 17.96 2,604
2014-02-18 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 217 17.96 3,897
2014-02-18 Wheeler Craig A (President) Sale 1,687 17.96 30,298
2014-02-12 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 32,900 17.96 590,884
2014-02-11 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 100 17.95 1,795
2014-01-09 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 27,159 19.50 529,600
2013-11-26 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 64 18.09 1,157
2013-11-25 Roach James M. (Senior VP, Development and Chi) Sale 192 17.77 3,411
2013-11-25 Leicher Bruce (SVP & General Counsel) Sale 13,492 17.92 241,817
2013-11-25 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 343 17.77 6,095
2013-11-25 Shea Richard P (SVP, CFO) Sale 277 17.77 4,922
2013-11-25 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 33,211 17.89 594,310
2013-11-25 Wheeler Craig A (President) Sale 2,215 17.77 39,360
2013-11-19 Roach James M. (Senior VP, Development and Chi) Sale 197 17.17 3,382
2013-11-19 Leicher Bruce (SVP & General Counsel) Sale 197 17.17 3,382
2013-11-19 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 217 17.17 3,725
2013-11-19 Shea Richard P (SVP, CFO) Sale 284 17.17 4,876
2013-11-19 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 217 17.17 3,725
2013-11-19 Wheeler Craig A (President) Sale 2,215 17.17 38,031
2013-11-18 Leicher Bruce (SVP & General Counsel) Sale 266 17.19 4,572
2013-11-18 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 214 17.19 3,678
2013-11-15 Roach James M. (Senior VP, Development and Chi) Sale 217 16.88 3,662
2013-11-15 Shea Richard P (SVP, CFO) Sale 210 16.88 3,544
2013-11-15 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 217 16.88 3,662
2013-11-15 Wheeler Craig A (President) Sale 1,772 16.88 29,911
2013-10-11 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 5,247 15.46 81,118
2013-08-27 Leicher Bruce (SVP & General Counsel) Sale 190 15.00 2,850
2013-08-27 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 64 15.00 960
2013-08-23 Roach James M. (Senior VP, Development and Chi) Sale 192 14.90 2,860
2013-08-23 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 344 14.90 5,125
2013-08-23 Shea Richard P (SVP, CFO) Sale 277 14.90 4,127
2013-08-23 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 212 14.90 3,158
2013-08-23 Wheeler Craig A (President) Sale 2,109 14.90 31,424
2013-08-20 Roach James M. (Senior VP, Development and Chi) Sale 197 14.47 2,850
2013-08-20 Leicher Bruce (SVP & General Counsel) Sale 197 14.47 2,850
2013-08-20 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 217 14.47 3,139
2013-08-20 Shea Richard P (SVP, CFO) Sale 284 14.47 4,109
2013-08-20 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 217 14.47 3,139
2013-08-20 Wheeler Craig A (President) Sale 2,109 14.47 30,517
2013-08-15 Roach James M. (Senior VP, Development and Chi) Sale 218 15.43 3,363
2013-08-15 Leicher Bruce (SVP & General Counsel) Sale 270 15.43 4,166
2013-08-15 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 218 15.43 3,363
2013-08-15 Shea Richard P (SVP, CFO) Sale 211 15.43 3,255
2013-08-15 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 218 15.43 3,363
2013-08-15 Wheeler Craig A (President) Sale 1,688 15.43 26,045
2013-07-26 Shea Richard P (SVP, CFO) Sale 30,000 16.61 498,300
2013-06-27 Shea Richard P (SVP, CFO) Sale 10,522 14.61 153,726
2013-06-19 Shea Richard P (SVP, CFO) Sale 21,550 14.61 314,845
2013-05-23 Roach James M. (Senior VP, Development and Chi) Sale 195 13.03 2,540
2013-05-23 Leicher Bruce (SVP & General Counsel) Sale 195 13.03 2,540
2013-05-23 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 246 13.03 3,205
2013-05-23 Shea Richard P (SVP, CFO) Sale 195 13.03 2,540
2013-05-23 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 214 13.03 2,788
2013-05-23 Wheeler Craig A (President) Sale 2,109 13.03 27,480
2013-05-21 Roach James M. (Senior VP, Development and Chi) Sale 197 12.83 2,527
2013-05-21 Leicher Bruce (SVP & General Counsel) Sale 197 12.83 2,527
2013-05-21 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 250 12.83 3,207
2013-05-21 Shea Richard P (SVP, CFO) Sale 197 12.83 2,527
2013-05-21 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 217 12.83 2,784
2013-05-21 Wheeler Craig A (President) Sale 2,109 12.83 27,058
2013-05-16 Shea Richard P (SVP, CFO) Sale 146 13.31 1,943
2013-05-15 Roach James M. (Senior VP, Development and Chi) Sale 217 13.33 2,892
2013-05-15 Leicher Bruce (SVP & General Counsel) Sale 269 13.33 3,585
2013-05-15 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 250 13.33 3,332
2013-05-15 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 217 13.33 2,892
2013-05-15 Wheeler Craig A (President) Sale 1,687 13.33 22,487
2013-03-15 Fanucci Marsha Sale 29,400 14.15 416,010
2013-03-05 Stoner Elizabeth Sale 2,040 14.00 28,560
2013-02-26 Roach James M. (Senior VP, Development and Chi) Sale 192 12.58 2,415
2013-02-26 Leicher Bruce (SVP & General Counsel) Sale 153 12.58 1,924
2013-02-26 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 233 12.58 2,931
2013-02-26 Shea Richard P (SVP, CFO) Sale 173 12.58 2,176
2013-02-26 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 183 12.58 2,302
2013-02-26 Wheeler Craig A (President) Sale 2,109 12.58 26,531
2013-02-25 Roach James M. (Senior VP, Development and Chi) Sale 189 12.43 2,349
2013-02-25 Leicher Bruce (SVP & General Counsel) Sale 189 12.43 2,349
2013-02-25 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 240 12.43 2,983
2013-02-25 Shea Richard P (SVP, CFO) Sale 189 12.43 2,349
2013-02-25 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 208 12.43 2,585
2013-02-25 Wheeler Craig A (President) Sale 2,109 12.43 26,214
2013-02-20 Roach James M. (Senior VP, Development and Chi) Sale 188 12.62 2,372
2013-02-20 Leicher Bruce (SVP & General Counsel) Sale 188 12.62 2,372
2013-02-20 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 239 12.62 3,016
2013-02-20 Shea Richard P (SVP, CFO) Sale 731 12.62 9,225
2013-02-20 Wheeler Craig A (President) Sale 2,109 12.62 26,615
2013-02-15 Roach James M. (Senior VP, Development and Chi) Sale 838 12.26 10,273
2013-02-15 Leicher Bruce (SVP & General Counsel) Sale 1,040 12.26 12,750
2013-02-15 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 970 12.26 11,892
2013-02-15 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 838 12.26 10,273
2013-02-15 Wheeler Craig A (President) Sale 6,750 12.16 82,080
2012-12-20 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Option Ex 7,200 .99 7,128
2012-11-27 Roach James M. (Senior VP, Development and Chi) Sale 192 10.53 2,021
2012-11-27 Leicher Bruce (SVP & General Counsel) Sale 136 10.53 1,432
2012-11-27 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 233 10.53 2,453
2012-11-27 Shea Richard P (SVP, CFO) Sale 174 10.53 1,832
2012-11-27 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 183 10.53 1,926
2012-11-27 Wheeler Craig A (President) Sale 2,109 10.53 22,207
2012-11-26 Roach James M. (Senior VP, Development and Chi) Sale 188 10.58 1,989
2012-11-26 Leicher Bruce (SVP & General Counsel) Sale 188 10.58 1,989
2012-11-26 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 239 10.58 2,528
2012-11-26 Shea Richard P (SVP, CFO) Sale 188 10.58 1,989
2012-11-26 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 206 10.58 2,179
2012-11-26 Wheeler Craig A (President) Sale 2,109 10.58 22,313
2012-11-21 Shea Richard P (SVP, CFO) Sale 197 10.74 2,115
2012-11-20 Roach James M. (Senior VP, Development and Chi) Sale 193 10.96 2,115
2012-11-20 Leicher Bruce (SVP & General Counsel) Sale 193 10.96 2,115
2012-11-20 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 244 10.96 2,674
2012-11-20 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 211 10.96 2,312
2012-11-20 Wheeler Craig A (President) Sale 2,109 10.96 23,114
2012-10-01 Stoner Elizabeth Sale 1,000 14.53 14,530
2012-08-29 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 2,397 14.57 34,924
2012-08-28 Roach James M. (Senior VP, Development and Chi) Sale 192 14.35 2,755
2012-08-28 Leicher Bruce (SVP & General Counsel) Sale 135 14.35 1,937
2012-08-28 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 232 14.35 3,329
2012-08-28 Shea Richard P (SVP, CFO) Sale 173 14.35 2,482
2012-08-28 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 182 14.35 2,611
2012-08-28 Wheeler Craig A (President) Sale 2,109 14.21 29,968
2012-08-23 Roach James M. (Senior VP, Development and Chi) Sale 187 13.64 2,550
2012-08-23 Leicher Bruce (SVP & General Counsel) Sale 187 13.64 2,550
2012-08-23 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 238 13.64 3,246
2012-08-23 Shea Richard P (SVP, CFO) Sale 380 13.64 5,183
2012-08-23 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 206 13.64 2,809
2012-08-23 Wheeler Craig A (President) Sale 2,109 13.57 28,619
2012-08-21 Roach James M. (Senior VP, Development and Chi) Sale 193 13.78 2,659
2012-08-21 Leicher Bruce (SVP & General Counsel) Sale 696 13.78 9,590
2012-08-21 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 244 13.78 3,362
2012-08-21 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 211 13.78 2,907
2012-08-21 Wheeler Craig A (President) Sale 2,109 13.63 28,745
2012-08-10 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 7,485 13.58 101,646
2012-08-01 Stoner Elizabeth Sale 1,010 14.21 14,352
2012-07-10 Shapiro Bennett M Sale 1,600 14.12 22,592
2012-06-15 Shea Richard P (SVP, CFO) Option Ex 46,728 .61 28,504
2012-06-11 Shapiro Bennett M Sale 400 14.84 5,936
2012-06-04 Stoner Elizabeth Sale 1,020 14.00 14,280
2012-05-29 Roach James M. (Senior VP, Development and Chi) Sale 192 13.93 2,674
2012-05-29 Leicher Bruce (SVP & General Counsel) Sale 135 13.93 1,880
2012-05-29 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 233 13.93 3,245
2012-05-29 Shea Richard P (SVP, CFO) Sale 173 13.93 2,409
2012-05-29 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 182 13.93 2,535
2012-05-29 Wheeler Craig A (President) Sale 2,110 13.79 29,096
2012-05-23 Roach James M. (Senior VP, Development and Chi) Sale 189 13.90 2,627

Insider trading activities including stock purchases, stock sales, and option exercises of MNTA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Momenta Pharmaceuticals Inc (symbol MNTA, CIK number 1235010) see the Securities and Exchange Commission (SEC) website.